Rezolve AI (RZLV) is in focus after unveiling Auditable AI, a new layer in its Brain Suite platform that is designed to make every product recommendation explainable, verifiable and understandable for retailers and consumers.

Rezolve AI's share price has been under pressure recently, with the stock down 3.98% on a 1-day share price return basis and 16.03% year to date, while the 3-year total shareholder return has declined 77.13%, suggesting sentiment is still cautious despite product progress like Auditable AI.

If this kind of AI-driven commerce story interests you, it could be a good time to see what else is out there and scan 63 profitable AI stocks that aren't just burning cash

Rezolve AI is pitching powerful technology in trusted enterprise AI, yet the stock has fallen sharply over three years. The real tension now is whether that gap reflects opportunity or a fair price for the risk.

Most Popular Narrative: 77.6% Undervalued

Rezolve AI's most followed narrative pins fair value at $10.75 a share versus a last close of $2.41. This sets up a wide gap that hinges on ambitious growth assumptions.

The structural shift of global retail spending toward online and omnichannel experiences, in a $30 trillion commerce market, favors Rezolve's Brain Suite as an infrastructure layer for agentic commerce, supporting sustained ARR expansion and improving operating leverage over time.

Curious what kind of revenue surge and margin uplift would need to line up for that fair value to hold? The narrative leans on rapid ARR scaling, improving profitability and a rich future earnings multiple to bridge today’s losses with that higher price tag.

Result: Fair Value of $10.75 (UNDERVALUED)

However, Rezolve AI still faces key hurdles, including the risk that aggressive ARR targets are missed and that acquisitions or services expansion dilute margins instead of improving them.

Another View: Rezolve AI Looks Expensive on Sales Today

The story around Rezolve AI's fair value is not one sided. On a simple P/S basis, the stock trades at about 20.5x sales, compared with 3.5x for the US Software industry and 10.5x for peers, while the fair ratio sits higher at 56.1x. That mix of rich current pricing, peer premium and even higher fair ratio points to wide uncertainty, so is this an early growth bet or just valuation risk?

To see how those sales based signals stack up in detail, it is worth walking through the full breakdown in our ratio workup, including how the fair ratio could act as a future anchor for Rezolve AI's valuation, in See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Given the mixed sentiment around Rezolve AI, it makes sense to review the underlying data yourself and weigh both the risks and the upside. To see the full balance of concerns and potential rewards that investors are focused on, start with these 1 key reward and 3 important warning signs

Looking for more Rezolve AI style investment ideas?

If Rezolve AI has caught your attention, do not stop here. Use the Simply Wall St screener tools to quickly surface other opportunities before the crowd does.

• Target potential mispricing by scanning companies that currently screen as 47 high quality undervalued stocks.
• Prioritise resilience first by focusing on businesses filtered through the 78 resilient stocks with low risk scores.
• Get ahead of the market by checking a screener containing 20 high quality undiscovered gems before they attract wider attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.